TheRecover.com, Adderall Abuse on College Campuses SAN

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
101
TheRecover.com, Adderall Abuse on College Campuses

SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Adderall is often prescribed to treat Attention Deficit Hyperactivity Disorder or ADHD (as well as narcolepsy and depression) and is a drug that can help people sit down and focus who normally could not do so for long stretches of time. But Adderall or speed, has taken on a more sinister role as it has become popular on college campuses as a chemical study aid for all nighters before exams. One study suggested that as many as 1 in 5 college students had taken Aderall or its twin Ridalin to help them study at some point.

Regardless of Adderall’s perceived benefits, it is an amphetamine, and under the Controlled Substance Act, Adderall is a Scheduled II controlled substance. By definition, this means that the drug runs a high risk of abuse and dependence. For a drug meant to increase focus, the drug can eventually take it all away. It is understood now that addiction to Adderall is medically comparable to addiction to cocaine and other amphetamines.

Adderall’s non-medical use and abuse is a highly documented problem on many campuses. According to a study by the National Survey on Drug Use and Health in 2009, there was substantial evidence that, not only did colleges have a growing problem with Adderall abuse , but there was also a direct correlation to its abuse and other types of drug abuse.

The study found that full-time college students, between the ages of 18 and 22, were twice as likely to abuse Adderall than those of the same age not in college (6.4 percent versus 3.0 percent).

Risks

The potential problem with Adderall and amphetamines is that as usage becomes habitual, tolerance also increases requiring higher and higher doses of the drug for similar effects which can lead to addiction. And overdosing on Aderall can be fatal. In 2005, Canada went so far as to ban Adderall XR after linking it to 20 deaths and 12 strokes, although the ban has since been lifted.

Amphetamines have also been linked in some cases to anxiety disorder, psychosis, and sexual dysfunction. Emergency medical attention should be sought if you experience any of the following symptoms: muscle twitches, hallucinations, delusions and irregular heart beat. Sudden heart attacks have been reported by some who showed no symptoms of prior heart problems.

Withdrawal

Furthermore, long-term use of Adderall can alter brain function permanently due to irregular blood flow to the brain which can lead to chronic convulsions and tremors. After prolonged and regular use of Adderall, stopping abruptly can also result in problems.

People suffer from withdrawal symptoms including tiredness, crankiness, extreme hunger, nightmares and severe, often suicidal, depression. A gradual reduction is highly recommended. Because of the highly addictive potential of Adderall and its increasing availability, professional help may be required in the form of rehab or substance abuse therapy.

For more information about the topic, you could visit this website  https://www.therecover.com/  or call through the numbers (888) 510-3898.

Contact : Company : The Recover Address : Temecula CA Contact Number : (888) 510-3898

A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Do...aa1f417e8a

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

Exro Technologies Reveals Quarterly Progress and Financial Insights

Updated Category News Views 362

Exro Technologies Reports First Quarter Results Exro Technologies Inc. (TSX: EXRO), a prominent tech company specializing in power control solutions for electric vehicles and energy storage, has recently announced its financial results for the first quarter of the year. This highlights their ongoing transition from technology validation towards commercial operations and...

Continue Reading
dsm-firmenich Appoints New Leaders to Propel Future Growth

Updated Category News Views 548

dsm-firmenich Welcomes New Executive Committee Members dsm-firmenich is set to usher in a transformative era by strengthening its Executive Committee, as it embarks on a journey to intensify its consumer-centered approach. This restructuring aims to solidify its standing as a top-tier partner in creation and innovation across the nutrition, health, and beauty sectors. The...

Continue Reading
Insight Partners Rolls Out $12.5B for Software Innovation Growth

Updated Category News Views 805

Insight Partners Launches New Funds to Propel Software Innovation Global software investor, Insight Partners, has recently celebrated a significant milestone by announcing the closing of its thirteenth flagship fund alongside a dedicated buyout co-invest fund, collectively known as "Fund XIII". This announcement is particularly special as it coincides with the firm's 30th...

Continue Reading
Acumatica's AI Innovations Transform Business Operations

Updated Category News Views 123

Acumatica's AI Innovations Transform Business Operations During an inspiring keynote at a recent summit, Acumatica showcased its commitment to revolutionizing business operations with an AI-first product strategy. This innovative approach aims to significantly enhance how small and mid-sized businesses operate, addressing the real-world challenges they face. With advanced...

Continue Reading
Microbiological Testing of Water Market Growth Forecasts

Updated Category News Views 101

The Expanding Microbiological Testing of Water Market As the demand for clean and safe water continues to surge, the global microbiological testing of water market is set to experience significant growth, reaching an impressive $2.3 billion by 2027, with a robust compound annual growth rate (CAGR) of 7.4%. The rising consciousness among consumers regarding the importance...

Continue Reading